Advertisement

Influence of Obesity on Outcomes in Atrial Fibrillation: Yet Another Obesity Paradox

      Abstract

      Background

      Obese patients have favorable outcomes in congestive heart failure, hypertension, peripheral vascular disease, and coronary artery disease. Obesity also has been linked with increased incidence of atrial fibrillation, but its influence on outcomes in atrial fibrillation patients has not been investigated. The objective of this research is to investigate the effect of obesity on outcomes in atrial fibrillation.

      Methods

      The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study was one of the largest multicenter trials of atrial fibrillation, with 4060 patients. Subjects were randomized to rate versus rhythm-control strategy. We performed a post hoc analysis of the National Heart, Lung and Blood Institute limited access dataset of atrial fibrillation patients who had body mass index (BMI) data available in the AFFIRM study. BMI data were not available on 1542 patients. Patients with BMI ≥18.5 were split into normal (18.5-25), overweight (25-30), and obese (>30) categories as per BMI (kg/m2). Multivariate Cox proportional hazards regression was used on the eligible 2492 patients. End points were all-cause mortality and cardiovascular mortality.

      Results

      Over three fourths of all patients in our cohort were overweight or obese. There were 304 deaths (103 among normal weight, 108 among overweight, and 93 among obese) and 148 cardiovascular deaths (54 among normal weight, 41 among overweight, and 53 among obese) over a mean period of 3 years of patient follow-up. On multivariate analysis, overweight (hazard ratio [HR] 0.64; 95% confidence interval [CI], 0.48-0.84; P=.001) and obese (HR 0.80; 95% CI, 0.68-0.93; P=.005) categories were associated with lower all-cause mortality as compared with normal weight. Overweight (HR 0.40; 95% CI, 0.26-0.60; P <.001) and obese patients (HR 0.77; 95% CI, 0.62-0.95; P=.01) also had lower cardiovascular mortality as compared with the normal weight patients.

      Conclusions

      Although in prior studies, obesity has been associated with increased risk of atrial fibrillation, an obesity paradox exists for outcomes in atrial fibrillation. Obese patients with atrial fibrillation appear to have better long-term outcomes than nonobese patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Braunwald E.
        Shattuck lecture—cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities.
        N Engl J Med. 1997; 337: 1360-1369
        • Miyasaka Y.
        • Barnes M.E.
        • Gersh B.J.
        • et al.
        Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence.
        Circulation. 2006; 114: 119-125
        • Benjamin E.J.
        • Wolf P.A.
        • D'Agostino R.B.
        • Silbershatz H.
        • Kannel W.B.
        • Levy D.
        Impact of atrial fibrillation on the risk of death: the Framingham Heart Study.
        Circulation. 1998; 98: 946-952
        • Wolf P.A.
        • Abbott R.D.
        • Kannel W.B.
        Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.
        Stroke. 1991; 22: 983-988
        • Flegal K.M.
        • Carroll M.D.
        • Ogden C.L.
        • Johnson C.L.
        Prevalence and trends in obesity among US adults, 1999-2000.
        JAMA. 2002; 288: 1723-1727
        • Vasan R.S.
        • Pencina M.J.
        • Cobain M.
        • et al.
        Estimated risks for developing obesity in the Framingham Heart Study.
        Ann Intern Med. 2005; 143: 473-480
        • Dublin S.
        • French B.
        • Glazer N.L.
        • et al.
        Risk of new-onset atrial fibrillation in relation to body mass index.
        Arch Intern Med. 2006; 166: 2322-2328
        • Frost L.
        • Hune L.J.
        • Vestergaard P.
        Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study.
        Am J Med. 2005; 118: 489-495
        • Wanahita N.
        • Messerli F.H.
        • Bangalore S.
        • et al.
        Atrial fibrillation and obesity—results of a meta-analysis.
        Am Heart J. 2008; 155: 310-315
        • Wang T.J.
        • Parise H.
        • Levy D.
        • et al.
        Obesity and the risk of new-onset atrial fibrillation.
        JAMA. 2004; 292: 2471-2477
        • Lauer M.S.
        • Anderson K.M.
        • Kannel W.B.
        • Levy D.
        The impact of obesity on left ventricular mass and geometry.
        JAMA. 1991; 266: 231-236
        • McGavock J.M.
        • Victor R.G.
        • Unger R.H.
        • Szczepaniak L.S.
        Adiposity of the heart, revisited.
        Ann Intern Med. 2006; 144: 517-524
        • Mureddu G.F.
        • de Simone G.
        • Greco R.
        • et al.
        Left ventricular filling pattern in uncomplicated obesity.
        Am J Cardiol. 1996; 77: 509-514
        • Pelat M.
        • Verwaerde P.
        • Merial C.
        • et al.
        Impaired atrial M(2)-cholinoceptor function in obesity-related hypertension.
        Hypertension. 1999; 34: 1066-1072
        • Pritchett A.M.
        • Jacobsen S.J.
        • Mahoney D.W.
        • et al.
        Left atrial volume as an index of left atrial size: a population-based study.
        J Am Coll Cardiol. 2003; 41: 1036-1043
        • Tsang T.S.
        • Barnes M.E.
        • Miyasaka Y.
        • et al.
        Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years.
        Eur Heart J. 2008; 29: 2227-2233
        • Kistler P.M.
        • Sanders P.
        • Morton J.B.
        • et al.
        Effect of body mass index on defibrillation thresholds for internal cardioversion in patients with atrial fibrillation.
        Am J Cardiol. 2004; 94: 370-372
        • Cha Y.M.
        • Friedman P.A.
        • Asirvatham S.J.
        • et al.
        Catheter ablation for atrial fibrillation in patients with obesity.
        Circulation. 2008; 117: 2583-2590
        • Ector J.
        • Dragusin O.
        • Adriaenssens B.
        • et al.
        Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation.
        J Am Coll Cardiol. 2007; 50: 234-242
        • Gami A.S.
        • Hodge D.O.
        • Herges R.M.
        • et al.
        Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation.
        J Am Coll Cardiol. 2007; 49: 565-571
        • Gami A.S.
        • Pressman G.
        • Caples S.M.
        • et al.
        Association of atrial fibrillation and obstructive sleep apnea.
        Circulation. 2004; 110: 364-367
        • Jongnarangsin K.
        • Chugh A.
        • Good E.
        • et al.
        Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation.
        J Cardiovasc Electrophysiol. 2008; 19: 668-672
        • Kanagala R.
        • Murali N.S.
        • Friedman P.A.
        • et al.
        Obstructive sleep apnea and the recurrence of atrial fibrillation.
        Circulation. 2003; 107: 2589-2594
        • Uretsky S.
        • Messerli F.H.
        • Bangalore S.
        • et al.
        Obesity paradox in patients with hypertension and coronary artery disease.
        Am J Med. 2007; 120: 863-870
        • Lavie C.J.
        • Milani R.V.
        • Ventura H.O.
        Obesity, heart disease, and favorable prognosis—truth or paradox?.
        Am J Med. 2007; 120: 825-826
        • Galal W.
        • van Gestel Y.R.
        • Hoeks S.E.
        • et al.
        The obesity paradox in patients with peripheral arterial disease.
        Chest. 2008; 134: 925-930
        • Lavie C.J.
        • Ventura H.O.
        • Milani R.V.
        The “obesity paradox”: is smoking/lung disease the explanation?.
        Chest. 2008; 134: 896-898
        • Lavie C.J.
        • Milani R.V.
        • Ventura H.O.
        Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.
        J Am Coll Cardiol. 2009; 53: 1925-1932
        • McAuley P.
        • Myers J.
        • Abella J.
        • Froelicher V.
        Body mass, fitness and survival in veteran patients: another obesity paradox?.
        Am J Med. 2007; 120: 518-524
        • Kannel W.B.
        • Abbott R.D.
        • Savage D.D.
        • McNamara P.M.
        Epidemiologic features of chronic atrial fibrillation: the Framingham study.
        N Engl J Med. 1982; 306: 1018-1022
      1. Atrial fibrillation follow-up investigation of rhythm management—the AFFIRM study design.
        Am J Cardiol. 1997; 79: 1198-1202
        • AFFIRM Investigators
        Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study.
        Am Heart J. 2002; 143: 991-1001
        • Wyse D.G.
        • Waldo A.L.
        • DiMarco J.P.
        • et al.
        A comparison of rate control and rhythm control in patients with atrial fibrillation.
        N Engl J Med. 2002; 347: 1825-1833
      2. Executive summary of the clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults.
        Arch Intern Med. 1998; 158: 1855-1867
        • Horwich T.B.
        • Fonarow G.C.
        Reverse epidemiology beyond dialysis patients: chronic heart failure, geriatrics, rheumatoid arthritis, COPD, and AIDS.
        Semin Dial. 2007; 20: 549-553
        • Kalantar-Zadeh K.
        • Block G.
        • Humphreys M.H.
        • Kopple J.D.
        Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.
        Kidney Int. 2003; 63: 793-808
        • Issac T.T.
        • Dokainish H.
        • Lakkis N.M.
        Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data.
        J Am Coll Cardiol. 2007; 50: 2021-2028
        • Lee S.H.
        • Chen Y.C.
        • Chen Y.J.
        • et al.
        Tumor necrosis factor-alpha alters calcium handling and increases arrhythmogenesis of pulmonary vein cardiomyocytes.
        Life Sci. 2007; 80: 1806-1815
        • Sawaya S.E.
        • Rajawat Y.S.
        • Rami T.G.
        • et al.
        Downregulation of connexin40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor.
        Am J Physiol Heart Circ Physiol. 2007; 292: H1561-H1567
        • Mohamed-Ali V.
        • Goodrick S.
        • Bulmer K.
        • et al.
        Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo.
        Am J Physiol. 1999; 277: E971-E975
        • Novo G.
        • Guttilla D.
        • Fazio G.
        • et al.
        The role of the renin-angiotensin system in atrial fibrillation and the therapeutic effects of ACE-Is and ARBS.
        Br J Clin Pharmacol. 2008; 66: 345-351
        • Weber M.A.
        • Neutel J.M.
        • Smith D.H.
        Contrasting clinical properties and exercise responses in obese and lean hypertensive patients.
        J Am Coll Cardiol. 2001; 37: 169-174
        • Rossi A.
        • Enriquez-Sarano M.
        • Burnett Jr, J.C.
        • et al.
        Natriuretic peptide levels in atrial fibrillation: a prospective hormonal and Doppler-echocardiographic study.
        J Am Coll Cardiol. 2000; 35: 1256-1262
        • Rienstra M.
        • Van Gelder I.C.
        • Van den Berg M.P.
        • et al.
        Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
        Europace. 2006; 8: 482-487
        • Wang T.J.
        • Larson M.G.
        • Levy D.
        • et al.
        Impact of obesity on plasma natriuretic peptide levels.
        Circulation. 2004; 109: 594-600
        • Rauchhaus M.
        • Coats A.J.
        • Anker S.D.
        The endotoxin-lipoprotein hypothesis.
        Lancet. 2000; 356: 930-933
        • Boos C.J.
        • Lip G.Y.
        • Jilma B.
        Endotoxemia, inflammation, and atrial fibrillation.
        Am J Cardiol. 2007; 100: 986-988
        • Horwich T.B.
        • Fonarow G.C.
        • Hamilton M.A.
        • et al.
        The relationship between obesity and mortality in patients with heart failure.
        J Am Coll Cardiol. 2001; 38: 789-795
        • Niraj A.
        • Pradhan J.
        • Fakhry H.
        • et al.
        Severity of coronary artery disease in obese patients undergoing coronary angiography: “obesity paradox” revisited.
        Clin Cardiol. 2007; 30: 391-396
        • Kalantar-Zadeh K.
        • Anker S.D.
        • Horwich T.B.
        • Fonarow G.C.
        Nutritional and anti-inflammatory interventions in chronic heart failure.
        Am J Cardiol. 2008; 101: 89E-103E
        • Kalantar-Zadeh K.
        • Kopple J.D.
        Obesity paradox in patients on maintenance dialysis.
        Contrib Nephrol. 2006; 151: 57-69
        • Lavie C.J.
        • Milani R.V.
        • Artham S.M.
        • Patel D.A.
        • Ventura H.O.
        The obesity paradox, weight loss, and coronary disease.
        Am J Med. 2009; 122: 1106-1114
        • Lavie C.J.
        • Osman A.F.
        • Milani R.V.
        • Mehra M.R.
        Body composition and prognosis in chronic systolic heart failure: the obesity paradox.
        Am J Cardiol. 2003; 91: 891-894